-
公开(公告)号:US20200237770A1
公开(公告)日:2020-07-30
申请号:US16843946
申请日:2020-04-09
IPC分类号: A61K31/5377 , C07D241/24 , C07D215/227 , C07D263/20 , C07D498/04 , A61P31/04 , A61K31/5365 , A61K31/4965 , A61K31/47
摘要: The present invention relates to therapeutic combinations of anti-bacterial agents linezolid, bedaquiline and pretomanid, and optionally with pyrazinamide, in a short-course oral dosage regimen for the treatment of tuberculosis.